FIRE1

FIRE1 is a Dublin-based medtech company developing the NORM heart failure management system, a remote monitoring implant designed to enable patients to control their fluid volume at home, similar to how continuous glucose monitors transformed diabetes care. The device received FDA Breakthrough Device Designation and has been successfully implanted in the first Irish patient at University Hospital Galway. FIRE1 has raised $210 million in total funding, including a $120 million round led by Polaris Partners and Elevage Medical Technologies.